Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris
Clinical trial NCT01320033 · COMPLETED
Trial details
- NCT number
- NCT01320033
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-29
- Primary completion
- 2012-01-03
- Enrollment
- 662
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.